N-Q 1 bcgnq.htm NQ~ BLUE CHIP GROWTH FUND T. Rowe Price Blue Chip Growth Fund, Inc. - 3/31/07 NQ

ITEM 1. SCHEDULE OF INVESTMENTS



T. ROWE PRICE BLUE CHIP GROWTH FUND     
Unaudited    March 31, 2007 
Portfolio of Investments   Shares  Value 
(Cost and value in $000s)     
 
COMMON STOCKS 98.4%     
CONSUMER DISCRETIONARY 10.6%     
Hotels, Restaurants & Leisure 2.7%     
International Game Technology  2,350,000  94,893 
Marriott, Class A  1,664,000  81,469 
McDonald's  340,000  15,317 
MGM Mirage (1)  250,000  17,380 
Wynn Resorts  707,000  67,066 
    276,125 
Household Durables 0.8%     
Fortune Brands  25,000  1,970 
Garmin  10,000  542 
Harman International  860,000  82,629 
    85,141 
Internet & Catalog Retail 1.1%     
Amazon.com (1)  2,710,000  107,831 
    107,831 
Media 1.3%     
Grupo Televisa, ADR  1,700,000  50,660 
Time Warner  1,300,000  25,636 
Viacom, Class B (1)  1,450,000  59,610 
    135,906 
Multiline Retail 2.9%     
Kohl's (1)  2,320,000  177,735 
Target  1,970,000  116,742 
    294,477 
Specialty Retail 1.2%     
Bed Bath & Beyond (1)  1,240,000  49,811 
Best Buy  250,000  12,180 
Home Depot  1,630,000  59,886 
    121,877 
Textiles, Apparel & Luxury Goods 0.6%     
Coach (1)  860,000  43,043 
Nike, Class B  170,000  18,064 
    61,107 
Total Consumer Discretionary    1,082,464 
CONSUMER STAPLES 5.1%     
Beverages 0.7%     
PepsiCo  1,150,000  73,094 
    73,094 
Food & Staples Retailing 2.9%     
CVS/ Caremark  5,200,000  177,528 
Sysco  1,030,000  34,845 
Wal-Mart  1,780,000  83,571 
    295,944 
Household Products 1.5%     
Procter & Gamble  2,450,000  154,742 
    154,742 
Total Consumer Staples    523,780 
ENERGY 7.4%     
Energy Equipment & Services 4.6%     
Baker Hughes  1,540,000  101,840 
Schlumberger  3,175,000  219,392 
Smith International  3,100,000  148,955 
    470,187 
Oil, Gas & Consumable Fuels 2.8%     
EOG Resources  460,000  32,816 
ExxonMobil  1,600,000  120,720 
Murphy Oil  923,100  49,294 
Sunoco  70,000  4,931 
Total, ADR  1,090,000  76,060 
    283,821 
 
Total Energy    754,008 
FINANCIALS 20.7%     
 
Capital Markets 12.3%     
Ameriprise Financial  610,000  34,855 
Charles Schwab  5,000,000  91,450 
E*TRADE Financial (1)  4,000,000  84,880 
Fortress Investment Group, Class A  50,000  1,434 
Franklin Resources  1,360,000  164,329 
Goldman Sachs  685,000  141,542 
Legg Mason  950,000  89,499 
Mellon Financial  1,375,000  59,318 
Merrill Lynch  860,000  70,236 
Morgan Stanley  1,600,000  126,016 
Northern Trust  1,330,000  79,986 
State Street  2,710,000  175,472 
UBS (CHF)  2,230,000  132,778 
    1,251,795 
Commercial Banks 0.7%     
Wells Fargo  2,000,000  68,860 
    68,860 
Consumer Finance 1.8%     
American Express  2,500,000  141,000 
SLM Corporation  1,085,000  44,377 
    185,377 
Diversified Financial Services 2.4%     
Chicago Mercantile Exchange Holdings  110,000  58,570 
Citigroup  2,300,000  118,082 
Deutsche Boerse (EUR)  145,000  33,258 
IntercontinentalExchange (1)  262,000  32,019 
    241,929 
Insurance 3.0%     
American International Group  2,410,000  162,000 
Hartford Financial Services  430,000  41,100 
Prudential Financial  1,100,000  99,286 
    302,386 
Thrifts & Mortgage Finance 0.5%     
Countrywide Financial  1,600,000  53,824 
    53,824 
Total Financials    2,104,171 
HEALTH CARE 18.1%     
Biotechnology 4.4%     
Amgen (1)  1,400,000  78,232 
Celgene (1)  1,400,000  73,444 
Genentech (1)  1,700,000  139,604 
Gilead Sciences (1)  2,100,000  160,650 
    451,930 
Health Care Equipment & Supplies 3.1%     
Alcon  140,000  18,455 
Baxter International  370,000  19,488 
Medtronic  2,400,000  117,744 
St. Jude Medical (1)  1,900,000  71,459 
Stryker  1,300,000  86,216 
    313,362 
Health Care Providers & Services 6.8%     
Aetna  1,760,000  77,070 
Cardinal Health  550,000  40,123 
Express Scripts (1)  880,000  71,034 
Humana (1)  665,000  38,583 
Laboratory Corporation of America (1)  340,000  24,694 
Medco (1)  1,325,000  96,102 
UnitedHealth Group  4,000,000  211,880 
WellPoint (1)  1,600,000  129,760 
    689,246 
Life Sciences Tools & Services 0.2%     
Thermo Fisher Scientific (1)  400,000  18,700 
    18,700 
Pharmaceuticals 3.6%     
Allergan  300,000  33,246 
Eli Lilly  550,000  29,540 
Johnson & Johnson  10,000  603 
Merck  430,000  18,993 
Novartis (CHF)  1,360,000  74,292 
Roche Holding (CHF)  550,000  97,518 
Schering-Plough  500,000  12,755 
Sepracor (1)  700,000  32,641 
Wyeth  1,330,000  66,540 
    366,128 
 
Total Health Care    1,839,366 
INDUSTRIALS & BUSINESS SERVICES 9.0%     
Aerospace & Defense 1.2%     
General Dynamics  910,000  69,524 
Rockwell Collins  500,000  33,465 
United Technologies  220,000  14,300 
    117,289 
Air Freight & Logistics 0.5%     
Expeditors International of Washington  1,150,000  47,518 
    47,518 
Industrial Conglomerates 4.4%     
GE  10,150,000  358,904 
Tyco International  3,000,000  94,650 
    453,554 
Machinery 2.9%     
Danaher  3,310,000  236,499 
Illinois Tool Works  880,000  45,408 
Joy Global  325,000  13,943 
    295,850 
 
Total Industrials & Business Services    914,211 
INFORMATION TECHNOLOGY 23.3%     
Communications Equipment 5.2%     
Cisco Systems (1)  7,000,000  178,710 
Corning (1)  1,760,000  40,022 
Juniper Networks (1)  4,480,000  88,166 
LM Ericsson (SEK)  16,000,000  58,870 
Nokia, ADR (1)  3,400,000  77,928 
QUALCOMM  1,960,000  83,614 
    527,310 
Computers & Peripherals 2.3%     
Apple (1)  1,475,000  137,042 
Dell (1)  1,600,000  37,136 
EMC (1)  3,580,000  49,583 
Hewlett-Packard  370,000  14,852 
    238,613 
Internet Software & Services 4.2%     
eBay (1)  2,450,000  81,217 
Google, Class A (1)  491,000  224,957 
Monster Worldwide (1)  1,270,000  60,160 
Yahoo! (1)  1,900,000  59,451 
    425,785 
IT Services 1.3%     
Accenture, Class A  250,000  9,635 
Automatic Data Processing (1)  2,680,000  117,250 
Broadridge Financial (1)  230,800  4,547 
Paychex  10,000  378 
    131,810 
Semiconductor & Semiconductor Equipment 4.9%     
Analog Devices  1,900,000  65,531 
Applied Materials  1,500,000  27,480 
ASML Holding, ADS (1)  1,500,000  37,125 
Intel  3,250,000  62,173 
Marvell Technology Group (1)  5,200,000  87,412 
Maxim Integrated Products  2,500,000  73,500 
Texas Instruments  2,170,000  65,317 
Xilinx  3,300,000  84,909 
    503,447 
Software 5.4%     
Adobe Systems (1)  1,825,000  76,102 
Autodesk (1)  1,630,000  61,288 
Electronic Arts (1)  880,000  44,317 
Intuit (1)  1,150,000  31,464 
Microsoft  9,100,000  253,617 
Oracle (1)  4,700,000  85,211 
    551,999 
 
Total Information Technology    2,378,964 
MATERIALS 0.8%     
 
Chemicals 0.8%     
Monsanto  1,500,000  82,440 
Total Materials    82,440 
TELECOMMUNICATION SERVICES 3.4%     
Wireless Telecommunication Services 3.4%     
America Movil, ADR, Series L  2,440,000  116,608 
American Tower Systems, Class A (1)  3,650,000  142,167 
Bharti Airtel (INR) (1)  370,000  6,581 
Rogers Communications, Class B  2,500,000  81,900 
Total Telecommunication Services    347,256 
Total Common Stocks (Cost $7,456,344)    10,026,660 
SHORT-TERM INVESTMENTS 0.0%     
Money Market Funds 0.0%     
T. Rowe Price Reserve Investment Fund, 5.37% (2)(3)  1,000  1 
Total Short-Term Investments (Cost $1)    1 

Total Investments in Securities
 
   
98.4% of Net Assets (Cost $7,456,345)  $  10,026,661 


 
 
     
  Denominated in U.S. dollars unless otherwise noted 
(1)  Non-income producing 
(2)  Seven-day yield 
(3)  Affiliated company - see Note 3 
ADR  American Depository Receipts 
ADS  American Depository Shares 
CHF  Swiss Franc 
EUR  Euro 
INR  Indian Rupee 
SEK  Swedish Krona 





The accompanying notes are an integral part of this Portfolio of Investments






T. Rowe Price Blue Chip Growth Fund   
Unaudited  March 31, 2007 
Notes To Portfolio of Investments   

NOTE 1 - SIGNIFICANT ACCOUNTING POLICIES

T. Rowe Price Blue Chip Growth Fund, Inc. (the fund), is registered under the Investment Company Act of 1940 (the 1940 Act) as a diversified, open-end management investment company. The fund seeks to provide long-term capital growth. Income is a secondary objective.

The accompanying portfolio of investments was prepared in accordance with accounting principles generally accepted in the United States of America, which require the use of estimates made by fund management. Fund management believes that estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the portfolio of investments may differ from the value the fund receives upon sale of the securities.

Valuation

The fund values its investments and computes its net asset value per share at the close of the New York Stock Exchange (NYSE), normally 4 p.m. ET, each day that the NYSE is open for business. Equity securities listed or regularly traded on a securities exchange or in the over-the-counter (OTC) market are valued at the last quoted sale price or, for certain markets, the official closing price at the time the valuations are made, except for OTC Bulletin Board securities, which are valued at the mean of the latest bid and asked prices. A security that is listed or traded on more than one exchange is valued at the quotation on the exchange determined to be the primary market for such security. Listed securities not traded on a particular day are valued at the mean of the latest bid and asked prices for domestic securities and the last quoted sale price for international securities.

Investments in mutual funds are valued at the mutual fund's closing net asset value per share on the day of valuation.

Other investments, including restricted securities, and those for which the above valuation procedures are inappropriate or are deemed not to reflect fair value are stated at fair value as determined in good faith by the T. Rowe Price Valuation Committee, established by the fund's Board of Directors.

Most foreign markets close before the close of trading on the NYSE. If the fund determines that developments between the close of a foreign market and the close of the NYSE will, in its judgment, materially affect the value of some or all of its portfolio securities, which in turn will affect the fund's share price, the fund will adjust the previous closing prices to reflect the fair value of the securities as of the close of the NYSE, as determined in good faith by the T. Rowe Price Valuation Committee, established by the fund's Board of Directors. A fund may also fair value securities in other situations, such as when a particular foreign market is closed but the fund is open. In deciding whether to make fair value adjustments, the fund reviews a variety of factors, including developments in foreign markets, the performance of U.S. securities markets, and the performance of instruments trading in U.S. markets that represent foreign securities and baskets of foreign securities. The fund uses outside pricing services to provide it with closing market prices and information used for adjusting those prices. The fund cannot predict when and how often it will use closing prices and when it will adjust those prices to reflect fair value. As a means of evaluating its fair value process, the fund routinely compares closing market prices, the next day's opening prices in the same markets, and adjusted prices.

Investment Transactions

Investment transactions are accounted for on the trade date.

New Accounting Pronouncement

In September 2006, the Financial Accounting Standards Board ("FASB") released the Statement of Financial Accounting Standard No. 157 ("FAS 157"), Fair Value Measurements. FAS 157 clarifies the definition of fair value and establishes the framework for measuring fair value, as well as proper disclosure of this methodology in the financial statements. It will be effective for the fund's fiscal year beginning January 1, 2008. Management is evaluating the effects of FAS 157; however, it is not expected to have a material impact on the fund's net assets or results of operations.

NOTE 2 - FEDERAL INCOME TAXES

At March 31, 2007, the cost of investments for federal income tax purposes was $7,456,345,000. Net unrealized gain aggregated $2,570,366,000 at period-end, of which $2,648,048,000 related to appreciated investments and $77,682,000 related to depreciated investments.

NOTE 3 - RELATED PARTY TRANSACTIONS

The fund may invest in the T. Rowe Price Reserve Investment Fund and the T. Rowe Price Government Reserve Investment Fund (collectively, the T. Rowe Price Reserve Investment Funds), open-end management investment companies managed by Price Associates and affiliates of the fund. The T. Rowe Price Reserve Investment Funds are offered as cash management options to mutual funds, trusts, and other accounts managed by Price Associates and/or its affiliates, and are not available for direct purchase by members of the public. The T. Rowe Price Reserve Investment Funds pay no investment management fees. During the three months ended March 31, 2007, dividend income from the T. Rowe Price Reserve Investment Funds totaled $357,000, and the value of shares of the T. Rowe Price Reserve Investment Funds held at March 31, 2007, and December 31, 2006, was $1,000 and $12,545,000, respectively.






Item 2. Controls and Procedures.

(a) The registrant's principal executive officer and principal financial officer have evaluated the registrant's disclosure controls and procedures within 90 days of this filing and have concluded that the registrant's disclosure controls and procedures were effective, as of that date, in ensuring that information required to be disclosed by the registrant in this Form N-Q was recorded, processed, summarized, and reported timely.

(b) The registrant's principal executive officer and principal financial officer are aware of no change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

Item 3. Exhibits.

Separate certifications by the registrant's principal executive officer and principal financial officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and required by Rule 30a-2(a) under the Investment Company Act of 1940, are attached.






SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

T. Rowe Price Blue Chip Growth Fund, Inc.

By  /s/ Edward C. Bernard 
  Edward C. Bernard 
  Principal Executive Officer 
 
Date  May 18, 2007 

     Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By  /s/ Edward C. Bernard 
  Edward C. Bernard 
  Principal Executive Officer 
 
Date  May 18, 2007 

By  /s/ Joseph A. Carrier 
  Joseph A. Carrier 
  Principal Financial Officer 
 
Date  May 18, 2007